Name: 6th CEN Conference
Start: 2026-05-18T08:30:00+02:00
End: 2026-05-21T18:00:00+02:00
Location: No location set

6th CEN Conference

from Monday, 18 May 2026 (08:30) to Thursday, 21 May 2026 (18:00)

Monday, 18 May 2026

09:00 A practical introduction to simulating complex trial designs: Full-day course - part 1
Full-day course - part 1
09:00 - 10:30
Room: Room 13 B

An introduction to Bayesian nonparametrics for causal inference: Full-day course - part 1
Full-day course - part 1
09:00 - 10:30
Room: Room 14

Bayesian borrowing in clinical trials: design choices, assessment of operating characteristics and reporting: Half-day course - part 1
Half-day course - part 1
09:00 - 10:30
Room: Room 13 A

10:30 Coffee break
Coffee break
10:30 - 11:00

11:00 A practical introduction to simulating complex trial designs: Full-day course - part 2
Full-day course - part 2
11:00 - 12:30
Room: Room 13 B

An introduction to Bayesian nonparametrics for causal inference: Full-day course - part 2
Full-day course - part 2
11:00 - 12:30
Room: Room 14

Bayesian borrowing in clinical trials: design choices, assessment of operating characteristics and reporting: Half-day course - part 2
Half-day course - part 2
11:00 - 12:30
Room: Room 13 A

12:30 Lunch
Lunch
12:30 - 14:00

14:00 A practical introduction to simulating complex trial designs: Full-day course - part 3
Full-day course - part 3
14:00 - 15:30
Room: Room 13 B

An introduction to Bayesian nonparametrics for causal inference: Full-day course - part 3
Full-day course - part 3
14:00 - 15:30
Room: Room 14

15:30 Coffee break
Coffee break
15:30 - 16:00

16:00 A practical introduction to simulating complex trial designs: Full-day course - part 4
Full-day course - part 4
16:00 - 17:30
Room: Room 13 B

An introduction to Bayesian nonparametrics for causal inference: Full-day course - part 4
Full-day course - part 4
16:00 - 17:30
Room: Room 14
Tuesday, 19 May 2026

08:30 Opening Ceremony

08:30 - 09:00
Room: Room 1 A
09:00 P1 Plenary Session: Tim Morris: Keynote lecture
Keynote lecture
09:00 - 10:00
Room: Room 1 A
Contributions

09:00 Simulation studies: bringing method to the madness - Tim Morris (Novartis Pharmaceuticals UK Ltd)
10:00 Coffee break / Poster session
Coffee break / Poster session
10:00 - 10:45
Room: Foyer
Poster session
10:00 - 17:15
Room: x Poster display area
Contributions

10:00 [01] A hybrid nonparametric framework for outlier detection in functional time series - David Solano (Research Group on Statistics, Econometrics and Health (GRECS). University of Girona)

10:05 [02] Adjust for Positional Uncertainty in Spatial Modeling - Manuel Moreno (universitat de girona)

10:10 [03] An Evaluation Metric for Detection-Based Object Counting - Agnieszka Kubik-Komar (University of Life Sciences in Lublin)

10:15 [04] Bridging Data Gaps for Better Groundwater Protection: Advanced Imputation Meets Spatial Modelling - Urszula Bronowicka-Mielniczuk (University of Life Sciences in Lublin/Department of Applied Mathematics and Computer Science)

10:20 [05] Comparing existing methods to address the multiplicity of analysis strategies: A case study in pharmacoepidemiology - Moritz Pamminger (Medical University of Vienna, Center for Medical Data Science, Institute of Clinical Biometrics)

10:25 [06] Comparison of statistical methods for analysis of treatment effects on repeated patient reported outcomes in randomized clinical trials - Agnieszka Król (AstraZeneca)

10:30 [07] Designing an integrated longitudinal data platform for exercise-based management of patients with multiple chronic conditions - Nasrin Salimian (Pardis Specialized Wellness Institute)

10:35 [08] Developing Statistical Power Estimation Models for Spatial Transcriptomics - Miglė Gervytė (Institute of Data Science and Digital Technologies, Faculty of Mathematics and Informatics, Vilnius University)

10:40 [09] Early molecular deviations as predictors of non-communicable diseases - Zita Zarándy (Center for Molecular Fingerprinting, Semmelweis University)

10:45 [10] Ensuring Quality in Preclinical Research: The Importance of Being Human - Tina Lang (Bayer AG)

10:50 [11] Exact conditional likelihood inference in meta-analysis for estimating risk ratio - Hisashi Noma (The Institute of Statistical Mathematics)

10:55 [12] Fraction-of-Time and robust periodic ARMA for improved analysis of digital health monitoring data - Stanislaw Leskow (Warsaw School of Economics (SGH))

11:00 [13] Impact of Tumor-Assessment Schedules on the Projected Timing of PFS Analyses in Oncology Trials - Laura Kohlhas (Cogitars)

11:05 [14] Influence of documentation quality on the reproducibility of animal research - Tomke Eiben (University of Applied Sciences and Arts, Hannover, Germany)

11:10 [15] Joint modelling of general and mental health using copula models: a simulation-based evaluation for COVID-19 health research. - Katarzyna Jagoda (University of Plymouth)

11:15 [16] MISSING OBSERVATIONS IN RESEARCH ON NITROGEN DIOXIDE CONTENT IN THE AIR - Dorota Domagała (University of Life Sciences in Lublin)

11:20 [17] Machine Learning Imputation of Air Pollutant Concentrations Using XGBoost - Dorota Domagała (University of Life Science)

11:25 [18] Modelling of alder pollen concentration - Małgorzata Graczyk (Poznań University of Life Sciences)

11:30 [19] Optimal Grouping for Weibull Modeling of Fertilizer Granule Strength - Paweł Kurasiński (University of Life Sciences in Lublin City: Lublin)

11:35 [20] Optimal cutoff selection for U-shaped prognostic variable in survival data with competing risk - Sook-young Woo (Samsung Medical Center)

11:45 [22] Polygenic Risk Modeling in Periodontitis: Insights from a Case-Control Study of 4,243 European Cases and Current Limitations - Gesa Richter (Department of Periodontology, Oral Medicine and Oral Surgery, Charité – Universitätsmedizin Berlin, Berlin, Germany)

11:50 [23] Predictive multivariate models and ordination analyses reveal drivers of degradation and plant invasion in the Biała and Czarna Łada river valleys - Monika Różańska-Boczula (University of Life Sciences in Lublin)

11:55 [24] Preprocessing of MALDI-TOF mass spectrometry data for prediction of antimicrobial resistance via machine learning - Dominic Enders (Institute of Biostatistics and Clinical Research, University of Münster)

12:00 [25] Realise D: compRehensive mEthodological and operational Approach to cLinical trIalS in ultra-rarE Diseases - Christoph Gerlinger (Bayer AG, Clinical Statistics and Analytics, Berlin and Department of Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland)

12:05 [26] Reanalysis and sensitivity analysis of overall survival and progression-free survival of pivotal randomized controlled trials in oncology - Giulia Varvarà (University of Rennes)

12:10 [27] Social capital, depression, place of residence and periods before and after the COVID-19 pandemic: a logistic regression analysis - Karolina Majdak (Jagiellonian University Medical College, Chair of Epidemiology and Preventive Medicine, Department of Medical Sociology)

12:15 [28] Survival of breast cancer patients treated at Tikur Anbessa specialized and Teaching Hospital, Addis Ababa Ethiopia. - Fatuma Hassen (Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.)

12:20 [29] The assessment of construct validity using Item Response Theory models: An example based on the Online Social Capital Index (OSCI) for middle-aged and older people - Michalina Gajdzica (Jagiellonian University - Medical College, Chair of Epidemiology and Preventive Medicine)

12:25 [30] Therapeutic Intervention Effects in Children with Autism Spectrum Disorder: A Pre–Post Statistical Analysis Using Respondent-Driven Sampling (RDS) - Syntia Souza (UFRPE)

12:30 [31] Trends and predictors of in-hospital survival among asphyxiated neonates admitted at Kilimanjaro Christian Medical Center, Northern Tanzania: Retrospective Cohort Study - Jovin Tibenderana (St Francis University College of Health And Allied Sciences)

12:35 [32] Twenty-Five Years of Oncology Clinical Trials: Trends from ClinicalTrials.gov (2000–2025) - Beth McDougall (Department of Statistics, Phastar)

12:40 [33] Win statistics in design and analysis of non-inferiority trials - Johanna Ledoux (University of Zurich, Department of Biostatistics)
10:45 Censored data 1
10:45 - 12:15
Room: Room 13 B
Contributions

10:45 Overview of methods for planning studies with multiple time to event endpoints - Ann-kathrin Ozga (Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf)

11:03 The impact of the number and the size of clusters on prediction performance of the stratified and the conditional shared gamma frailty Cox proportional hazards models - Daniele Giardiello (Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, School of Medicine and Surgery, University of Milano-Bicocca,)

11:21 Evaluating Statistical Methods for Multiple Time-to-Event Endpoints: A Simulation Study on Recurrent and Competing Events - Duoerkongjiang Alidan (Institute of Medical Biometry and Epidemiology; University Medical Center Hamburg-Eppendorf (UKE))

11:39 Prognostic Models for Recurrent Event Data - Victoria Watson (Phastar)

11:57 Unsure about the Markov assumption? A comparison of transition probability estimators in multi-state models - Merle Munko (Otto-von-Guericke University Magdeburg)
High dimensional data 1
10:45 - 12:15
Room: Room 14
Contributions

10:45 Unraveling Aging in the CSF Proteome: A Systematic Comparison of Variable-Selection Methods for Protein Risk Score Modeling - Sathish Ravindranth (TU Dortmund University)

11:03 Detecting gene-environment interactions to guide personalized intervention: boosting distributional regression for polygenic scores - Qiong Wu (University of Marburg)

11:21 Regularized Multi-Omics Regression Modelling for Transcriptomic–Proteomic Integration in Mice with induced liver Damage. - Ngoune Darwin (TU Dortmund University)

11:39 StabCell: A stability-selection framework with error control for clustering and differential expression analysis of scRNA-seq data - Niklas Lück (TU Dortmund University, IUF - Leibniz Research Institute for Environmental Medicine)

11:57 A Nested Cross-Validation Framework for Leakage-Free Calibration of Adaptive Elastic-Net Regression in High-Dimensional Data - Gul Inan (Koc University)
IS1: Past and Future of Bayesian Biostatistics
10:45 - 12:15
Room: Room 1 A
Contributions

10:45 Bayesian Highs and Lows: A Pharma Industry Perspective - Simon Wandel (Novartis Pharma AG)

11:15 Bayesian approaches in time of ML and AI - Katja Ickstadt (Department of Statistics, TU Dortmund University)

11:35 Lessons learned in the last 25 years - Gerhard Nehmiz (Consultant to Boehringer Ingelheim Pharma GmbH&Co. KG)

11:55 Discussant - Reinhard Vonthein
Other 2
10:45 - 12:15
Room: Room 12
Contributions

10:45 Nonparametric analysis of covariance in Mann-Whitney effects - Konstantin Emil Thiel (Paracelsus Medical University City: Salzburg)

11:03 Enabling Inference in Small Samples: Bayesian Estimation of Nonparametric Effects - Levin Wiebelt (Charité - Universitätsmedizin Berlin)

11:21 A New Approach to the Nonparametric Behrens-Fisher Problem with Compatible Confidence Intervals - Stephen Schüürhuis (Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin)

11:39 Graph-theoretic determinants of causal discovery performance in feedback-driven biological networks - Markus Schepers (Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University)

11:57 The Chicken or The Egg? Causal Inference Methods for Cross-Lagged Effects in Longitudinal Panel Data - Tanya Toluay (Charité - Universitätsmedizin Berlin, Insitute of Biometry and Clinical Epidemiology City: Berlin)
Statistical hypothesis testing 1
10:45 - 12:15
Room: Room 13 A
Contributions

10:45 Bootstrap calibration: A flexible tool to obtain (simultaneous) confidence, prediction and tolerance intervals - Max Menssen (University Medical Center Göttingen, Department of Medical Statistics, Göttingen, Germany)

11:03 Multiple-use prediction and calibration for all future values: exact simultaneous tolerance bands for regression - Yang Han (University of Manchester)

11:21 Minimum area confidence set optimality for simultaneous confidence bands for percentiles with applications to drug shelf‐life estimation - Lingjiao Wang (Warwick Medical School, University of Warwick)

11:39 Detecting day-to-day effects in concentration-response experiments in toxicology - Julia Eichhorn (TU Dortmund University)

11:57 Choice of the hypothesis matrix for usual quadratic forms - Paavo Sattler (TU Dortmund; RWTH Aachen)
TC1: 50th anniversary of the closed testing procedure
10:45 - 12:15
Room: Room 1 B
Contributions

10:45 The invention of the closed testing procedure and early developments - Markus Neuhäuser (Koblenz University of Applied Sciences)

11:03 Closed Testing, Interim Analysis and Adaptations – History, Methods, and Modern Challenges - Franz König (Medical University of Vienna)

11:21 Principles in Harmony: Closed Testing Meets the Partitioning and Projection Principle - Werner Brannath (University of Bremen)

11:39 Graphical Approaches for Transparent Closed Testing - Martin Posch (Medical University of Vienna)

11:57 Multiple hypotheses testing in clinical trials beyond familywise error rate control - Frank Bretz (Novartis)
12:15 Lunch break
Lunch break
12:15 - 13:45
13:45 Censored data 2
13:45 - 15:15
Room: Room 13 B
Contributions

13:45 mRNA COVID-19 vaccination in pregnancy and risk of pregnancy loss: a progressive multistate model to account for time-dependent exposure - Lukas Lohse (Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy)

14:03 Estimating a treatment effect for survival when membership of the target population is partially hidden - Marilena Müller (German Cancer Research Cente)

14:21 Comparison of survival outcomes with a partly unknown, time-dependent, exogenous treatment – a problem in paediatric SCT-studies - Martina Mittlböck (Institute of Clinical Biometrics, CeDAS, Medical University of Vienna)

14:39 Detecting Early and Late Divergences in Survival Curves Using Nonparametric Effect Measures - Jonas Beck (DKFZ)

14:57 Evaluation of Z-tests to compare fixed time survival probabilities using stratified Kaplan-Meier estimates with different variance estimators and weights - Hannes Buchner (Staburo GmbH)
IS2: Multiple tests beyond parametric assumptions
13:45 - 15:15
Room: Room 1 A
Contributions

13:45 Multiple Comparison Procedures for Simultaneous Inference in General Factorial Design for Multivariate Functional Data under Non-parametric Assumptions - Łukasz Smaga (Adam Mickiewicz University)

14:15 From group-sequential to flexible adaptive designs for time-to-event endpoints: Assumptions for valid multiplicity control - Moritz Fabian Danzer (University of Münster)

14:35 Wild bootstrapping the (asymptotic) joint distribution of rank-based statistics - Lukas Mödl (Institut für Biometrie und Klinische Epidemiologie, Charité -- Universitätsmedizin Berlin)

14:55 Beyond Independence: A Unified Approach to the Multiple Nonparametric Behrens-Fisher Problem - Erin Sprünken (Charité - Universitätsmedizin Berlin)
Machine learning and data science 1
13:45 - 15:15
Room: Room 14
Contributions

13:45 Identifying Post-COVID Risk Factors with Model-Agnostic Feature Importance - Lukas Burk (Leibniz Institute for Prevention Research and Epidemiology - BIPS)

14:03 MACHINE LEARNING ALGORITHM TO PREDICT BIOMARKER LEVELS USING METABOLOMICS DATA - Fabiola Del Greco M. (Institute of Biomedicine - Eurac research)

14:21 From claims to care: Machine learning algorithm to classify urinary tract infection cases using Swiss health insurance data - Soheila Aghlmandi (University of Basel)

14:39 Machine Learning Model for Multi-Ancestry Fine-Mapping from Summary Statistics - Shizhe Xu (University of Oxford)

14:57 Metabolite discovery in tumor tissue with a self-supervised deep learning approach on MALDI-MSI data - Annalena Weissert (TU Dortmund University)
Statistical hypothesis testing 2
13:45 - 15:15
Room: Room 13 A
Contributions

13:45 Test of independence in a three-level model - Anna Szczepańska-Alvarez (Poznań University of Life Sciences)

14:03 Testing Independence in Functional Data Using the Distance of Mean Embedding - Jędrzej Wydra (Adam Mickiewicz University)

14:21 Alert identification in time-dose-response data - Lucia Ameis (Institute of Medical Statistics and Computational Biology (IMSB), Faculty of Medicine, University of Cologne)

14:39 Assessing the Impact of Distributional Assumption Violations on Outlier-Detection Methods in Clinical Audits - Anqi Sui (University College London)
Statistical modelling 1
13:45 - 15:15
Room: Room 12
Contributions

13:45 The effect of attentional control on postural stability in young and older adults - Jakub Malik ([1] Poznan University of Physical Education - Faculty of Sport Sciences; [2] Adam Mickiewicz University - Faculty of Mathematics and Computer Science)

14:03 Lowering the Barrier: An Intuitive Framework for Optimal Design in Immunization Studies - Stefan Embacher (Medical University of Graz)

14:21 Deriving Duration Time from Occupancy Data – A case study in the length of stay in Intensive Care Units for COVID-19 patients - Göran Kauermann (Ludwig-Maximilians-Universität München)

14:39 Novel Sample Size Calculation Approaches for Risk Prediction Model Development with Clustered Binary Data - Rumana Omar (University College London)
TC2: Interpretable Bayesian modelling of highdimensional / complex problems in molecular biomedicine
13:45 - 15:15
Room: Room 1 B
Contributions

13:45 Probabilistic Variable Importance: A Bayesian Perspective on Interpretable Machine Learning - Christian Staerk (IUF – Leibniz Research Institute for Environmental Medicine & TU Dortmund University)

14:03 An interpretable varying coefficients approach to non-linear regression - Francesco Stingo (affiliation: University of Florence)

14:21 A modelling framework for detecting and leveraging node-level information in Bayesian network inference - Hélène Ruffieux (University of Cambridge)

14:39 Generalized promotion time cure model: A new modeling framework to identify cell-type-specific genes and improve survival prognosis - Zhi Zhao (University of Oslo)

14:57 Discussant - Manuela Zucknick
15:15 Coffee break
Coffee break
15:15 - 15:45
15:45 Bayesian methods 1
15:45 - 17:15
Room: Room 12
Contributions

15:45 A Bayesian approach to decision making in early development clinical trials: An Open-source solution - Audrey Yeo (Finc Research)

16:03 Bayesian Methods in Registered Clinical Trials: A Systematic Review of Studies on ClinicalTrials.gov Through 2024 - Giles Partington (Phastar)

16:21 Robust calibrated priors for the BLRM that reconcile implicit design beliefs - Lukas Widmer (Novartis Pharma AG)

16:39 Assessing Air Quality in Nigerian States Using a Bayesian Hierarchical Environmetrics Model - Oladapo Oladoja (Abiola Ajimobi Technical University, Ibadan, Nigeria)
Clinical trials 1
15:45 - 17:15
Room: Room 13 B
Contributions

15:45 A novel method for inserting dose levels mid-trial in early phase combination studies - Matthew George (Phastar)

16:03 Adaptive Designs in Fast-Track Registration Processes for Digital Health Applications - Liane Kluge (University of Bremen)

16:21 adagraph: An R Package for Graph-Based Multiple Testing in Adaptive Trial Designs - Benjamin Fallmann (Medical University of Vienna, Center for Medical Data Science, Institute of Medical Statistics)

16:39 An adaptive design for interim dose selection and addition for the treatment of whorm infections - Sonja Zehetmayer (Medical University of Vienna City: Vienna)

16:57 Confidence intervals for two-stage adaptive designs with subpopulation selection - Enyu Li (Clinical Trials Unit, University of Warwick)
IS3: Survival Analysis for Excess Mortality: Insights and Innovations
15:45 - 17:15
Room: Room 1 A
Contributions

15:45 Model extensions for relative survival to assess excess mortality during the COVID-19 pandemic - Liesbeth C De Wreede (Department of Biomedical Data Sciences, Leiden University Medical Center)

16:15 Modelling excess mortality comparing to a control population: A combined additive and relative hazards model - Caroline Dietrich (Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet)

16:35 Regression models in the extended multi-state model using relative survival - Damjan Manevski (Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana)

16:55 A penalized spline additive hazards model for modeling excess mortality - Mar Rodriguez-Girondo (LUMC)
Machine learning and data science 2
15:45 - 17:15
Room: Room 14
Contributions

15:45 Supervised Machine Learning Models for Longitudinal and Clustered Data - Maxi Schulz (University Medical Center Göttingen, Department of Medical Statistics)

16:03 Can We Trust Interpretable Machine Learning Methods for Longitudinal Risk Prediction? - Julia Höpler (Leibniz Institute for Prevention Research and Epidemiology – BIPS, Faculty of Mathematics and Computer Science – University of Bremen)

16:21 Flexible nonparametric bootstrapping for machine learning validation studies based on hierarchical data - Max Westphal (Fraunhofer MEVIS)

16:39 Explaining Mixed Effect Machine Learning with Shapley Value - Pat Vatiwutipong (Mahidol University)

16:57 ML with U-smile Visualization: A Novel Approach to Imbalanced Classification Without Thresholds - Barbara Więckowska (Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznan, Poland)
Streitberg- and Lienert-Awards
15:45 - 17:15
Room: Room 13 A
Contributions

15:45 Optimal designs for non-linear segmented regression - Jan-Bernd Igelmann (TU Dortmund University)

16:03 Adaptive group sequential designs for event-driven survival trials - Alexandra Nagel (University of Ulm, METRONOMIA Clinical Research GmbH)

16:21 A Statistical Approach to Latent Dynamic Modeling with Differential Equations - Maren Hackenberg (Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg. Freiburg Center for Data Analysis, Modeling, and AI, University of Freiburg)

16:39 Variable Selection via Fused Sparse-Group Lasso Penalized Multi-state Models Incorporating Molecular Data - Kaya Miah (Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany)
TC3: Estimation after Adaptive Testing
15:45 - 17:15
Room: Room 1 B
Contributions

15:45 Estimation after an adaptive design - Chris Jennison (University of Bath, UK)

16:03 Estimation in confirmatory clinical trials planned with an adaptive design - a regulatory perspective - Florian Klinglmueller (Austrian Agency for Health and Food Safety)

16:21 Estimation for adaptive designs - a methodological overview - David Robertson (MRC Biostatistics Unit, University of Cambridge)

16:39 Point and interval estimation of treatment effects in adaptive clinical trials – past experiences and future developments - Ekkehard Glimm (Novartis Pharma)

16:57 Discussant - Frank Bretz
17:30 Welcome Reception
Welcome Reception
17:30 - 19:30
Wednesday, 20 May 2026
09:00 P2 Plenary Session: Kirsten Schorning: Keynote lecture
Keynote lecture
09:00 - 10:00
Room: Room 1 A
Contributions

09:00 Optimal design and Analysis in cytotoxicity experiments -- Bridging the gap between statistics and toxicology - Kirsten Schorning (TU Dortmund University)
10:00 Coffee break / Poster session
Coffee break / Poster session
10:00 - 10:45
Room: Foyer

Poster session - continued

10:00 - 15:15
Room: x Poster display area
10:45 Censored data 3
10:45 - 12:15
Room: Room 13 B
Contributions

10:45 Inference in pseudo-observation-based regression using (biased) covariance estimation and naive bootstrapping - Simon Mack (RWTH Aachen University)

11:03 Evaluating selective‐inference methods for Lasso in survival analysis: a comparative simulation study - Lena Schemet (University of Augsburg)

11:21 Evaluation of Joint Models and Related Approaches for Long-Term Risk Prediction from Short-Term Data - Moritz Madern (Medical University of Vienna, Center for Medical Data Science, Institute of Clinical Biometrics)

11:39 Comparing variable selection in Cox and accelerated failure time models: noncollapsibility, the phantom hazard - Lorena Hafermann (Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin)
High dimensional data 2
10:45 - 12:15
Room: Room 14
Contributions

10:45 Individuality and information content of infrared molecular profiles: insights from a large longitudinal health-profiling study - Kosmas Kepesidis (Ludwig-Maximilians-Universität München)

11:03 Statistical basis for precision screening with infrared molecular fingerprints: functional data decomposition and lung cancer signals - Lea Gigou (Department of Statistics, Ludwig Maximilian University of Munich; Max Planck Institute of Quantum Optics; Center for Molecular Fingerprinting)

11:21 Integrative Prediction Models for Multi-Omics Data with Missing Modalities - Marina Bleskina (Institute of Medical Biometry and Statistics, University of Lübeck, University Hospital of Schleswig-Holstein, Campus Lübeck)

11:39 Inference for Functional Matched Pairs Designs with Missingness - Marléne Baumeister (TU Dortmund University, Department of Statistics)

11:57 Informative Subsampling via Optimal Design for Efficient Training on Large and High-Dimensional Genomic Data - Subhadra Dasgupta (IUF - Leibniz Research Institute for Environmental Medicine)
IS4: Questions of Experimental Design and Statistical Analysis in Preclinical Research
10:45 - 12:15
Room: Room 1 A
Contributions

10:45 From design to decision: A case study in preclinical pooled CRISPR demonstrating statistical opportunity - Natasha Karp (AstraZeneca)

11:15 Optimizing Preclinical Research: Sample Size Planning and Sequential Designs - Frank Konietschke (Institute of Biometry, Charité - Universitätsmedizin Berlin)

11:35 Statistical Planning and Reporting for Multi-Laboratory Preclinical Trials - María Arroyo Araujo (Berlin Institue of Health, Charité Universitätsmedizin)

11:55 The Experimental Unit Information Index: Balancing Evidentiary Value and Sample Size of Adaptive Designs - Leonhard Held (University of Zurich)
Methods in epidemiology 1
10:45 - 12:15
Room: Room 12
Contributions

10:45 Inferring the causal effect direction in genetic association studies: An application to broad depression, obesity, and asthma - Sharon Lutz (Harvard Medical School)

11:03 Methodological and Practical Challenges in Developing a Cardiac Allocation Score - Leonie Lenz-Seraphin (Medical University Vienna, Center for Medical Data Science, Institute of Clinical Biometrics)

11:21 Timeliness of Polio Vaccination during 2019-21 in India: A finite mixture modeling analysis - Sumit Das (Scientist - I, All India Institute of Medical Sciences (AIIMS))

11:39 Advancing mixed-effects random forests to predict BMI development in children and adolescents based on multi-cohort data - Jiumeng Zhang (Leibniz-Institute for Prevention Research and Epidemiology - BIPS)

11:57 Estimating prevalence of micronutrient deficiency across multiple biomarkers: Approaches for generalized linear and linear mixed models - Steffen Hadasch (National Institute of Public Health, University of Southern Denmark)
Statistical modelling 2
10:45 - 12:15
Room: Room 13 A
Contributions

10:45 Comparison of statistical methods for dealing with deviations in concentration-response curves - Huiying Zhou Zhou (TU Dortmund University)

11:03 A comparison of variable selection approaches for spline regression - Franziska Kappenberg (University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics and Epidemiology)

11:21 A Clustered-Metric Simulation Study Comparing Flexible Regression Techniques for Non-Linear Associations - Theresa Ullmann (Institute of Clinical Biometrics, Center for Medical Data Science, Medical University of Vienna)

11:39 Detection of changes in time series of preclinical measurements for selecting Virtual Control Groups - Wiebke Dammann (TU Dortmund University - Department of Statistics)

11:57 Limitations and Challenges of Mixed Models Repeated Measures (MMRM) Analysis - Moses Mwangi (Kenya Medical Research Institute, Kenya; University of Hasselt, Belgium)
YSS1 (ROeS)
10:45 - 12:15
Room: Room 1 B
Contributions

10:45 Navigating Multiplicity in Multiverse Analyses: A Simulation Study and Case Application to Lung Cancer Staging Using SEER Data - Gloria Brigiari (Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova)

11:03 Modeling Antibody Kinetics in Pregnant and Lactating Women Following COVID-19 and Tdap Vaccination - Lukas Frank Buchhäusl (Medical University of Graz)

11:21 Edgington's Method for Random-Effects Meta-Analysis - David Kronthaler (Epidemiology, Biostatistics and Prevention Institute, Department of Biostatistics, University of Zurich)

11:39 Evaluation of cancer screening programmes: integration of the biological tumour growth model into the MOCCI method - Ema Požek (Faculty of Medicine, University of Ljubljana)

11:57 Comparative Analysis of Classification Models for Pharmaceutical Permeability Prediction - Jana Habus-Korbar (Student at University of Zagreb, Faculty of Science, Department of Mathematics)
12:15 Lunch break
Lunch break
12:15 - 13:45
13:45 Clinical trials 2
13:45 - 15:15
Room: Room 13 B
Contributions

13:45 A systematic empirical comparison of different statistical approaches for a multi- aspect analysis of clinical trial data in rare diseases - Martin Geroldinger (Research Program Biomedical Data Science, Paracelsus Medical University Salzburg)

14:03 Assessing covariate-adjusted risk differences in small-sample trials: A comparative evaluation of statistical methods - Martin Schnuerch (Global Biostatistics & Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. K)

14:21 Allocation Bias in Rare Diseases Clinical Trials with Multiple Endpoints - Stefanie Schoenen (RWTH Aachen)

14:39 When randomization is not random: Allocation bias in small sample, group sequential randomized clinical trials - Daniel Bodden (RWTH Aachen University)

14:57 Multiple Treatment Arms, Multiple Biases? Allocation and chronological biases in platform trials - Nico Bruder (Institute of Medical Statistics, Medical University of Vienna)
IS5: Navigating in murky waters: reproducing preclinical findings
13:45 - 15:15
Room: Room 1 A
Contributions

13:45 Reproducibility and Ethics in Nonclinical Statistics: Building Trust - Helena Geys (Johnson&Johnson Innovative Medicine R&D)

14:15 The Impact of Methodological Rigor on Reproducibility in Biomedical Research - Ulf Toelch (BIH QUEST Center for Responsible Research)

14:35 Planning animal experiments based on estimation error considerations - Dario Zocholl (University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics and Epidemiology)

14:55 Sample Size Minimisation in Preclinical Animal Trials - Nicole Ellenbach (Institute for Medical Information Processing, Biometry and Epidemiology, Faculty of Medicine, LMU Munich, Germany and Munich Center for Machine Learning, Munich, Germany)
Machine learning and data science 3
13:45 - 15:15
Room: Room 14
Contributions

13:45 A Comprehensive Comparison of Methods for Quantifying Similarity of Datasets - Marieke Stolte (TU Dortmund University, Department of Statistics)

14:03 A New Approach to Distinctness Testing - Laura Slebioda (Department of Mathematical and Statistical Methods, Poznań University of Life Sciences)

14:21 Predicting mixture of experts performance by generalized estimating equations - Małgorzata Ćwiklińska-Jurkowska (Department of Biostatistics and Biomedical Systems Theory, Nicolaus Copernicus University)

14:39 Predicting Ordinal Outcome Using Interpretable Artificial Representative Tree with Conformal Uncertainty Quantification - Lea Kronziel (University of Lübeck)

14:57 modgo 2.0: an R package for synthetic data generation to mimic original study data - Andreas Ziegler (Cardio-CARE)
Methods in epidemiology 2
13:45 - 15:15
Room: Room 13 A
Contributions

13:45 Detection of Measurement Errors and Heterogeneity During the Collection of Observational Data: A Simulation Study - Ronja Foraita (Leibniz Institute for Prevention Research and Epidemiology - BIPS)

14:03 Detecting Temporal Measurement Heterogeneity in Cohort Studies: Lessons from the Study of Health in Pomerania - Carsten Schmidt (University Medicine Greifswald City: Greifswald)

14:21 Navigating Complexities in Assessing Systemic Health Effects of Tattoos in a Population-Based Cohort - Narges Ghoreishi (Department Exposure, Unit of Epidemiology statistics and exposure modelling, German Federal Institute for Risk Assessment (BfR))

14:39 Beyond Case Counts: Simulation Evidence for Probability-Based Pandemic Surveillance - Inken Siems (Trier University)
Other 3
13:45 - 15:15
Room: Room 12
Contributions

13:45 Feasibility of Photoplethysmography for Heart Rate Asymmetry Assessment: A Comparative Study using the Autonomic Aging Database - Rafał Pawłowski (Collegium Medicum of Nicolaus Copernicus University)

14:03 Assessing the Reliability of Virtual Control Groups in Preclinical Toxicology - Timur Tug (Fraunhofer Institute for Toxicology and Experimental Medicine ITEM)

14:21 Modeling data with values above the upper limit of quantitation - Ulbrich Hannes-friedrich (Bayer AG, Pharmaceuticals)

14:39 Consideration of missing values in sample size calculation using multiple imputation - Teresa Byczkowski (Institute of Medical Biometry, Heidelberg University)

14:57 Calibrating machine learning approaches for probability estimation in case of the absence of calibration data - Eleonora Di Carluccio (Cardio-CARE)
YSS2 (DR & PLR)
13:45 - 15:15
Room: Room 1 B
Contributions

13:45 Hypothesis Testing in Ill-Conditioned Functional Response Models - Natalia Stefańska (Adam Mickiewicz University)

14:00 missKnockoffs: A Robust Approach to Variable Selection in Incomplete Omics Data under False Discovery Control - Dominik Nowakowski (Medical University of Bialystok, Department of Biostatistics and Medical Informatics)

14:15 Conditional distribution function-based measure for independence testing of functional data. - Filip Pieczątkiewicz (Adam Mickiewicz University)

14:30 Combining machine learning methods for subgroup identification in time-to-event data with approximate Bayesian computation for bias correction - Henrik Stahl (University of Applied Sciences Darmstadt)

14:45 Estimating the Causal Effect of a Cumulative Exposure on an Outcome in Studies Prone to Confounding and Irregular Visits - Mathilde Dicaire-Cartier (Institute for Medical Information Processing, Biometry, and Epidemiology, Faculty of Medicine, LMU Munich, Germany; Munich Center for Machine Learning, Munich, Germany; Department of Mathematics and Statistics, Université de Montréal, Montréal, Canada)

15:00 Variable Selection in Meta-Regression with Suspected Interaction Effects - Paula Lorenz (TU Dortmund University)
16:00 Annual German Region Meeting

16:00 - 19:00
Room: Room 1 A

Excursions
Excursions
16:00 - 19:00
Room: x Outdoor

19:30 Gala Dinner
Gala Dinner
19:30 - 22:30
Thursday, 21 May 2026
09:00 P3 Plenary Session: Susanne Strohmaier: Keynote lecture
Keynote lecture
09:00 - 10:00
Room: Room 1 A
Contributions

09:00 Causal inference in practice – One (?) estimand, many (!) analytical decisions - Susanne Strohmaier (Medical University of Vienna, Center for Public Health, Department of Epidemiology City: Vienna)
10:00 Coffee break / Poster session
Coffee break / Poster session
10:00 - 10:45
Room: Foyer

Poster session - continued

10:00 - 17:15
Room: x Poster display area
10:45 Clinical trials 3
10:45 - 12:15
Room: Room 13 B
Contributions

10:45 A randomized basket trial design for dose optimization based on Bayesian model averaging using spike-and-slab priors - Belay Birlie Yimer (1. Astellas Pharma Europe Ltd., Addlestone, United Kingdom)

11:03 A Basket Trial Design for Unequal Sample Sizes Based on Power Priors - Lukas Baumann (Institute of Medical Biometry, University of Heidelberg)

11:21 How to optimize dynamic borrowing in basket trials – A utility-based framework. - Lukas D Sauer (Institute of Medical Biometry, Heidelberg University)

11:39 AI-Assisted Methodology Validation Before Data Collection: The E-PICOS Framework for Robust Clinical Trials - Arzu Kanik (AB Health Tech)

11:57 Using Confidence Distributions in Final and Interim Analyses for Single-Arm Studies or Platform Trials Consisting of Single-Arm Studies - Günter Heimann (Independent Consultant)
Ecological and agricultural statistics 1
10:45 - 12:15
Room: Room 12
Contributions

10:45 Clustering of indicator species according to soil properties in the regeneration phase of pedunculate oak (Quercus robur L.) forests - Anamarija Jazbec (University of Zagreb Faculty of Forestry and Wood Technology)

11:03 Quality over Quantity? - The optimised allocation of quality samples in Bavarian post-registration trials in perennial ryegrass - Anne-katrin Gorn (Bavarian Research Center for agriculture)

11:21 Challenges and Perspectives on Using Environmental Covariates in Multi Environment Trials A Case Study in Sugar Beet - Maksym Hrachov (University of Hohenheim)

11:39 Optimizing the allocation of trials to sub-regions in crop variety testing: different conditions in different years - Maryna Prus (University of Hohenheim)

11:57 Assessment of a Low-Cost System for 3D Image Acquisition in Beef Cattle - Milene Figueira (UFRPE)
Evidence synthesis 1
10:45 - 12:15
Room: Room 14
Contributions

10:45 Parametric nonlinear dose-response meta regression - Christian Ritz (National Institute of Public Health (SDU))

11:03 Meta-analyses based on previous meta-analyses - Christian Röver (Department of Medical Statistics, University Medical Center Göttingen)

11:21 Proper Back-Transformations for the Random-Effects Model in Meta-Analysis - Jan-Bernd Igelmann (TU Dortmund University)

11:39 Bayesian conjugate analysis for federated statistical inference - Peter Degen (Center for Reproducible Science and Research Synthesis, University of Zurich)

11:57 Evaluating Nonparametric Combination Methods for Aggregating N-of-1 Trials: A Simulation-Based Comparison with Meta-Analysis - Anna Eleonora Carrozzo (Salzburg Research, Austria / Paris Lodron University of Salzburg, Austria)
IS6: Big Data in Biomedicine: Innovations Across Imaging and Omics
10:45 - 12:15
Room: Room 1 A
Contributions

10:45 Functional Data Analysis of Head Impact Exposure of College Football Athletes - Jaroslaw Harezlak (Indiana University)

11:15 Quantile regression in genomics: a new lens for genetic discovery and phenotype prediction - Iuliana Ionita-Laza (Columbia University)

11:35 Degradation Graphs Reveal Hidden Proteolytic Activity in Peptidomes - Jonas Wallin (department of statistics)

11:55 Relative quantification of proteins with shared peptides: a weight-based approach - Mateusz Staniak (University of Wrocław)
Methods for diagnostics studies 1
10:45 - 12:15
Room: Room 13 A
Contributions

10:45 Strategies for dealing with outliers in (semi-)parametric estimation of reference intervals and standard deviation scores - Andreas Gleiss (Medical University of Vienna, Center for Medical Data Science)

11:03 A Novel Approach to Diagnostic Evaluation: Prevalence-Corrected Precision-Recall Curves - Ilker Unal (Cukurova University Faculty of Medicine Dept of Biostatistics)

11:21 Covariate adjustment, factorial designs and clustered data in diagnostic accuracy studies - Philipp Weber (Institute of Medical Biometry and Epidemiology)

11:39 Enhancing Efficiency in Cancer Drug Testing using Nonparametric Approaches - Sunil Mathur (Weill Cornell Medical College)

11:57 Comparison of different methods for the meta-analysis of diagnostic test accuracy studies – a simulation study - Ferdinand Valentin Stoye (Biostatistics and Medical Biometry, Medical School OWL, Bielefeld University)
TC4: Biometrics in the era of AI
10:45 - 12:15
Room: Room 1 B
Contributions

10:45 On the Role of Biometry in AI Projects - Björn-hergen Laabs (University Medical Center Göttingen)

11:03 ChatGPT as a Tool for Biostatisticians - Dennis Dobler (RWTH Aachen University)

11:21 Teaching Biostatistics in Times of AI - Ursula Berger (LMU Munich)

11:39 Panel discussion - Frank Bretz Presenters Sarah Friedrich-Welz
12:15 Lunch break
Lunch break
12:15 - 13:45
13:45 Clinical trials 4
13:45 - 15:15
Room: Room 13 B
Contributions

13:45 Difference-in-difference estimators in randomized trials with external controls - Christiana Drake (University of California, Davis)

14:03 Evidence Generation Using External Controls: Opportunities and Challenges – A Regulator’s Perspective - Armin Schüler (BfArM - Federal Institute for Drugs and Medical Devices)

14:21 Bayesian Methods Integrating Causal Inference Approaches for Borrowing Historical Control Data in RCTs: A Neutral Comparison Study - David Jesse (F. Hoffmann-La Roche AG, Basel, Switzerland; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany)

14:39 Identification of subtrial-specific optimal biological dose (OBD) with robust borrowing of information - Zhi Cao (MRC Biostatistics Unit, University of Cambridge)
High dimensional data 3
13:45 - 15:15
Room: Room 14
Contributions

13:45 Integrating functional motif discovery and statistical learning approaches for advanced blood glucose prediction in real-world conditions - Sara Garber (Department of Statistics and Data Science, University of Augsburg)

14:03 Statistical end-to-end analysis of large-scale microbial growth data with DGrowthR - Medina Feldl (Institute of Computational Biology, Helmholtz Munich)

14:21 Population Matching to Enhance Back-Translation Between Clinical Trials and Biobank Data for Drug Target Discovery - Han Chiam (Medical University of Vienna)

14:39 Entropy Adjusted Graphical Lasso for Sparse Precision Matrix Estimation - Vahe Avagyan (Wageningen University & Research)
IS7: Methods to improve the practical usefulness of biomedical research
13:45 - 15:15
Room: Room 1 A
Contributions

13:45 Systematic Review and Meta-analysis of Animal Studies as Tools for Strengthening Research Integrity - Kimberley Wever (Radboud university medical center)

14:15 Quality assessment of proposals for animal studies and corresponding publications - Florian Frommlet (Medical University Vienna)

14:35 From the Classroom to the Clinic: Teaching Reproducibility in Statistics Education - Samuel Pawel (University of Zurich)

14:55 Discussant - Ulrich Dirnagl
Missing data 1
13:45 - 15:15
Room: Room 13 A
Contributions

13:45 Prediction in the presence of missing values. Are there credible alternatives to imputation-based use of the predictive density? - Bart Mertens (Leiden University Medical Centre)

14:03 Impact of imputation on individual cough alert system with incomplete baseline monitoring - Dörte Huscher (Institute of Biometry and Clinical Epidemiology, and Berlin Institute of Health, Charité - Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin)

14:21 The performance paradox: understanding the discrepancy between the performance of imputation approaches for survival models with missing covariates in simulation studies and real data - Edouard F. Bonneville (LMU Munich, and Munich Center for Machine Learning)

14:39 Handling Missing Data in Life Science: A Comparative Study of Imputation Methods for Medical Data. - Maria Thurow (TU Dortmund University)

14:57 Evaluating the Impact of Missing Data Imputation Methods on Bias and Covariate Balance in Propensity Score Analysis: A Simulation Study - Saghar Garayemi (Augsburg University)
Other 1
13:45 - 15:15
Room: Room 12
Contributions

13:45 Statistical methods to reduce Selection Bias in Dose-Finding Studies with Binary Endpoints - Alexandra Balzer (Institute of Medical Biometry Heidelberg University Hospital)

14:03 Comparison of ANOVA methods for experiments in the nested block design - Konrad Banaś (Department of Mathematical and Statistical Methods City: Poznań)

14:21 Rectangular augmented row-column designs generated from contractions - Hans-peter Piepho (Universiy of Hohenheim City: Stuttgart)

14:39 Effect of using textbook field plans without randomization - Jens Hartung (University of applied science Weihenstephan-Triesdorf)

14:54 Socio-spatial characterization of sub-sewersheds for wastewater-based epidemiology: Developing and evaluating two estimators for population-related variables - Yassine Talleb (TU Dortmund University)
TC5: Statistical issues in health care provider comparisons
13:45 - 15:15
Room: Room 1 B
Contributions

13:45 Causal Inference for Healthcare Profiling in Low-Event Settings - Sharon-lise Normand (Harvard Medical School)

14:03 Measuring performance for end-of-life care - Sebastien Haneuse (Harvard T.H. Chan School of Public Health)

14:21 Timely yearly assessment of follow-up outcomes using a period-based survival data approach - Lisa Steyer (Federal Institute for Quality Assurance and Transparency in Healthcare)

14:39 Improved predictions of quality of care indicators in the tail of its distribution - Els Goetghebeur (Ghent University)

14:57 Comparing the usefulness of patient and clinician reported outcomes measures to compare providers of arthroscopic rotator cuff repair – Methodological considerations - Werner Vach (Basel Academy for Quality and Research in Medicine)
15:15 Coffee break
Coffee break
15:15 - 15:45
15:45 Clinical trials 5
15:45 - 17:15
Room: Room 13 B
Contributions

15:45 Assessment of Global Evidence Against Homogeneity for Exhaustive Subgroup Treatment Effect Plots - Björn Bornkamp (Novartis Pharma AG)

16:03 Comparing adverse event probabilities in a hypothetical world without consent withdrawals or treatment switches - Judith Vilsmeier (Institute of Statistics, Ulm University)

16:21 Counterfactual Uncertainty Quantification in Personalized Medicine: A Statistical Framework for RCTs - Xingya Wang (Department of Mathematics, The University of Manchester)

16:39 Continuous Monitoring in Early Phase Oncology: A Standardized, Patient-Centric Approach - Kuzko Aleksandra (AstraZeneca)

16:57 Blinded continuous monitoring for continuous outcomes - Longhao Xu (Department of Medical Statistics, University Medical Center Göttingen)
IS8: Regularization methods and their applications in the work of IQWiG and IQTIG
15:45 - 17:15
Room: Room 1 A
Contributions

15:45 Regularization methods in clinical biostatistics: State-of-the-art and possibilities for improvement - Sarah Friedrich-Welz (University of Augsburg)

16:15 The Firth correction - a recap - Georg Heinze (Medical University of Vienna, Center for Medical Data Science, Institute of Clinical Biometrics)

16:35 Regularization methods in the evaluation of hospital quality - Jona Cederbaum (Federal Institute for Quality Assurance and Transparency in Healthcare (IQTIG))

16:55 Regularization methods in clinical biostatistics: Evaluation of adverse events in early benefit assessment using Firth correction for Cox models in the case of zero events - Lars Beckmann (IQWiG)
Machine learning and data science 4
15:45 - 17:15
Room: Room 14
Contributions

15:45 Generative Adversarial Networks For Mortality Modelling - Łukasz Głąb (SGH Warsaw School of Economics)

16:03 Lesion Network Mapping based Convolutional Neural Networks: Predictive Performance and Interpretability - Matthias Becher (Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institut für Biometrie und klinische Epidemiologie, Germany)

16:21 Deep Learning Strategies for Rare and Common Brain Disease Diagnostics from Medical Imaging - Anna Mamchych (Adam Mickiewicz University)

16:39 From Data to Decisions: Enhancing the Reliability of Random Forest Predictions with optRF - Thomas Martin Lange (Breeding Informatics, Georg August University of Göttingen)
Open and reproducible research 1
15:45 - 17:15
Room: Room 13 A
Contributions

15:45 Addressing the researchers' degree of freedom using multiple marginal models - Anne-Laure Boulesteix (Ludwig-Maximilian University Munich and Munich Center of Machine Learning)

16:03 OMOP ETL Pipeline Implementation for Tuberculosis Data Standardisation at Douala General Hospital, Cameroon - Brenda Yankam Mbouamba (Ruhr University Bochum)

16:21 Living Synthetic Benchmarks: A Neutral and Cumulative Framework for Simulation Studies - František Bartoš (University of Amsterdam)

16:39 How many subgroup analyses are false (-positives or negatives)? – Evidence from p-value distributions of interaction tests and mixture models in diabetes research - Oliver Kuss (German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Institute for Biometrics and Epidemiology)

16:57 Improving clinical and methodological research in the health sciences – on the crucial role of reporting guidelines and structured reporting - Willi Sauerbrei (Institute of Medical Biometry and Statistics, Medical Center - University of Freiburg)
17:30 Closing Ceremony

17:30 - 18:00
Room: Room 1 A

Choose timezone